
Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease
Keywords: ANIT, alpha-naphthylisothiocyanate; ADP, adenosine diphosphate; PAR, protease activated receptor; H&E, hematoxylin and eosin; CK-19, cytokeratin-19; ALT, alanine aminotransferase; TGFβ, transforming growth factor beta; COL1A1, type I collagen; ITGβ6, inte